BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 27, 2004
View Archived Issues
Synta Pharmaceuticals gives update on clinical status of its products
Read More
Cambridge Antibody Technology and Lonza extend manufacturing agreement
Read More
Sicor stockholders approve merger
Read More
Azelaic acid found more effective than metronidazole in moderate papulopustular rosacea
Read More
Analgesic effects of gabapentin in patients with chronic daily headache
Read More
Novel EP4 agonists with potential utility in female infertility, asthma, etc.
Read More
Lilly presents new GLP-1 analogues in a recent patent
Read More
New TPO mimetics in early development at GSK
Read More
Two novel series of NF-kappaB activation inhibitors patented by GSK
Read More
Tanabe Seiyaku scientists claim new inhibitors of alpha4 integrin-mediated cell adhesion
Read More
Takeda scientists describe new GRK2 inhibitors for heart failure therapy
Read More
New CGRP antagonists identified by BMS researchers
Read More
SPP-301 shows good tolerability and pharmacokinetics in healthy subjects
Read More
CR-4: a novel tyrosine kinase inhibitor active against ALL and AML cell lines
Read More
Samaritan Pharmaceuticals reports drug development update
Read More
CPMP recommends use of Ambirix in children
Read More
FR-210575: a candidate for the treatment of stroke and other neurodegenerative disorders
Read More
CPMP recommends extension of Paxene indications
Read More
European approval recommended for Lysodren
Read More
EntreMed identifies peptide fragment of tissue factor pathway inhibitor
Read More
Successful pre-IND meeting for Itax leads to phase III studies
Read More
Velcade recommended for approval in Europe
Read More
FDA extends review of anidulafungin NDA
Read More
Syrrx reports DP4 atomic structure, selects DP4 inhibitor candidates
Read More
RegeneRx licenses out European rights to TB4
Read More
Kowa and Nikken enter olmesartan medoxmil copromotion agreement
Read More
Evra available in Canada
Read More
Lundbeck and Pharmexa enter option agreement
Read More
Profile Therapeutics makes good progress during last six months of 2003
Read More
Diabetic endothelial dysfunction in ZDF rats normalized with chronic AVE-7688 treatment
Read More
Inex and Enzon partner to develop Onco TCS
Read More
Axonyx acquires interest in Oxis International
Read More